Improving Healthspan and Increasing Lifespan
Phoenix SENOLYTIX™ is an affiliate of SENOTHERAPEUTIX, Inc.
Phoenix SENOLYTIX is a longevity company using advanced technologies to develop novel gene therapies targeting the fundamental mechanisms of aging. Its lead programs are based on it’s two novel gene therapy platforms, ApoptiCIDe-CE™, our purposeful cell elimination gene therapy platform, and ApoptiCIDe-RGT™, our regulated gene therapy platform. Both utilize our proprietary enhanced, cell elimination switch technology that we originally developed as CaspaCIDe™ , as founders of Bellicum Pharmaceuticals, for use in T cells.